Maryland Maternal Opioid Misuse (MOM) Model
***
Applications for the 2021 MOM Model Provider Incentive Program are now being accepted! Please follow
this link for additional information.***
Background
The Maryland Department of Health (the Department) launched its Maternal Opioid Misuse (MOM) model in January 2020, with funding the Center for Medicare and Medicaid Innovation (CMMI) and in collaboration with the Centers for Medicare and Medicaid Services (CMS). The model is a five-year, multi-pronged approach to combating the nation’s opioid crisis by addressing fragmentation in the care of pregnant and postpartum Medicaid beneficiaries with opioid use disorder (OUD).
With over 21,000 individuals of childbearing age diagnosed with OUD in Maryland, substance use is a leading cause of maternal death and has significant impact on the approximately 1,500 infants born to Medicaid beneficiaries with OUD in Maryland per year. The MOM model focuses on improving clinical resources and enhancing care coordination to Medicaid beneficiaries with OUD during and after their pregnancies.
Maryland is one of 10 states to secure funding for the MOM model. Between 2020 and 2024, the state will receive $3.6 million, with the opportunity to receive an additional $1.5 million based on achievement of performance targets. Maryland’s Medicaid program will work collaboratively with its nine managed care organizations (MCOs) and stakeholders to improve case management practices, bolster health information technology and strengthen provider capacity throughout the state.
Update: Due to the COVID-19 pandemic, MOM model service provision will be delayed from January 2021 until July 2021.
Resources and Information
For more information regarding the MOM Model and subawardees, please visit the following webpages.
Maryland’s MOM Model
MCO Design Collaborative Materials
Resources
Stakeholder Questions: Please direct comments, questions or suggestions regarding Maryland's Maternal Opioid Misuse Model to
MDH.MOMModel@maryland.gov
This project is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $3.6 million with 100 percent funded by CMS/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CMS/HHS, or the U.S. Government.